Oncology Infographic: Real-time Patient Insights from Medisafe
Highlights from the Oncology Infographic
- The U.S. ranks amongst the lowest in reported oncology aherence as compared to other developed nations
- Unlike other therapeutic classes, patients on oncology meds are adherent every day of the week
- The highest reported oncology adherence rates on Medisafe are prior to breakfast and dinner hours
- Patients taking more oncology meds are more adherent
- Of the top 10 most adherent cancer drugs on Medisafe, Amgen and Novartis hold two spots each
What insights can we discover about your brand? Contact us to find out!
Full Oncology Adherence Insights
Top 15 Most Adherent Countries For Cancer Meds
- Italy: 84%
- Switzerland: 84%
- Brazil: 83%
- Spain: 83%
- Mexico: 82%
- Canada: 81%
- France: 81%
- New Zealand: 81%
- Germany: 80%
- UK: 80%
- Australia: 80%
- USA: 79%
- Chile: 74%
- Israel: 74%
- Netherlands: 72%
How Day Of Week Affects Cancer Med Adherence
- Sunday: 82%
- Monday: 84%
- Tuesday: 83%
- Wednesday: 84%
- Thursday: 83%
- Friday: 83%
- Saturday: 82%
Adherence Rates By Type Of Cancer
- Thyroid: 96%
- Bone: 84%
- Leukemia: 84%
- Non-Hodgkin’s Lymphoma: 84%
- Recovery/ Blood Cells: 84%
- Colorectal: 78%
- Gastric: 77%
- Prostate: 77%
- Renal: 77%
- Breast: 76%
- Melanoma: 76%
- Lymphoma: 75%
- Myeloma: 72%
- Brain: 68%
- Lung: 67%
- Pancreatic: 60%
How Number Of Cancer Meds Influences Adherence
- 1 Med: 85%
- 2 Meds: 85%
- 3 Meds: 86%
- 4 Meds: 87%
- 5 Meds: 88%
- 6+ Meds: 90%
Top 10 Cancer Drugs With Highest Adherence
Brand | Company | Adherence |
Xgeva | Amgen | 91% |
Sprycel | BMS | 90% |
Zometa | Novartis | 88% |
Imbruvica | Pharmacyclics | 88% |
Neupogen | Amgen | 84% |
Palbociclib | Pfizer | 84% |
Rituxan | Biogen, Genetech | 84% |
Femara | Novartis | 84% |
Zytiga | Janssen Biotech | 83% |
Lenalidomide | Celgene | 81% |